It has been proposed that the soluble form of ACE2 may inhibit the binding of SARS-CoV-2 to membrane-bound ACE2 and therefore proposed a soluble recombinant of ACE2 as a potential treatment for COVID-19.36 The gene discussed is ACE2; the disease is COVID-19.